The largest database of trusted experimental protocols

H d val leu lys afc

Manufactured by AnaSpec

H-D-Val-Leu-Lys-AFC is a synthetic peptide substrate designed for the detection and measurement of trypsin-like serine protease activity. It is a tetrapeptide consisting of histidine, D-valine, leucine, and lysine, with a 7-amino-4-trifluoromethylcoumarin (AFC) fluorescent reporter group attached to the C-terminus.

Automatically generated - may contain errors

2 protocols using h d val leu lys afc

1

Plasmin Activity Quantification in E. faecalis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasmin activity assays were performed as previously described with minor modifications18 (link). E. faecalis were grown overnight in tryptone yeast media. OD600 was normalized by dilution to 0.1, and samples were diluted 10x in the final reaction. Bacteria were incubated with 250nM human glu-plasminogen (Haematologic technologies) with or without 10mM TXA (Fisher) for two hours at 37°C. A final concentration of 4nM uPA or pro-uPA (Biovision) were added and incubation proceeded for 20 minutes. A final concentration of 6μM plasmin-specific fluorogenic substrate (H-D-Val-Leu-Lys-AFC, AnaSpec) was added immediately prior to a 30-minute kinetic fluorescent read at 380/500nm. For assays of uPA activity, PLG was omitted and a substrate specific to uPA (Z-Gly-Gly-Arg-AMC, Bachem) was utilized. When assays were performed in human plasma, fluorescence was read for 120 minutes total. Plasmin or uPA activity is expressed as initial reaction velocity calculated from change in fluorescence over time during the initial phase of the reaction, when pseudo-first order kinetics determine the rate.
+ Open protocol
+ Expand
2

Plasmin Activation Assay with Streptokinase

Check if the same lab product or an alternative is used in the 5 most similar protocols
To measure plasmin activation in a clot-dependent manner using bacterial plasmin activator streptokinase (SK), patient plasma samples and control pooled plasma (George King Bio-Medical Inc., Overland Park, KS) were diluted 1:5, 1:10, and 1:20 in HEPES buffer. Increasing concentrations of TXA (Pfizer, New York, NY) were added to control plasma or purified plasminogen (Haemtech, Essex Junction, VT). Diluted plasma (or purified plasminogen) and fluorogenic substrate (H-D-Val-Leu-Lys-AFC, Anaspec, Fremont, CA) were added in triplicate to a 96-well plate. Plasmin activation was initiated by the addition of 0.5 U/μL bacterial streptokinase (SK) (MilliporeSigma, Burlington, MA) and fluorescence was measured every 30 s for 1 h using a Synergy 2 plate reader (Biotek, Winooski, VT). Rates of plasmin generation were calculated based on change in fluorescence over time and were reported as a percent of control pooled plasma [9 (link)].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!